$98.12
Moderna is a US biotechnology company. Its COVID-19 vaccine was approved for use in the UK on 8 January, 2021 - the third vaccine to get this approval. Moderna is expanding its production capability in Europe and UK supplies are expected in spring 2021. Moderna's share price rose after it announced encouraging early results from vaccine trials in November 2020, so news of an approved vaccine could see the share price rise further. The company uses a molecule called "messenger RNA" (or mRNA), which exists in the cells in your body, to produce medicines. We've compiled what you need to know about how to buy Moderna shares.
How to buy shares in Moderna
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: MRNA in this case.
- Research Moderna shares. The platform should provide the latest information available.
- Buy your Moderna shares. It's that simple.
Our top picks for where to buy Moderna shares:
Fees for buying 10x Moderna shares with popular platforms
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
Platform | Customer rating | Platform fee | Min. initial deposit | Trading fee estimate | |
---|---|---|---|---|---|
![]() |
★★★★★ | £0 - £9.99 | No minimum | £4.77 £812.49 total |
Capital at risk |
![]() |
★★★★★ | £0 | $50 | £4.04 £811.76 total |
Capital at risk |
![]() |
★★★★★ | £0 | £250 | £12.31 £820.04 total |
Capital at risk |
![]() |
Not yet rated | £0 | No minimum | £4.04 £811.76 total |
Capital at risk |
![]() |
Not yet rated | £0 | No minimum | £4.04 £811.76 total |
Capital at risk |
![]() |
★★★★★ | £0 | £1 | £20.03 £827.75 total |
Capital at risk |
![]() |
Not yet rated | £0 | No minimum | £2.91 £810.63 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Alternative ways to invest in Moderna
Latest updates for Moderna
August 18, 2023: Moderna announced positive results for its updated COVID vaccine and the stock price has responded positively.
August 8, 2023: Moderna stock has dropped 6% yesterday and is down by over 13% in the past week as the company missed earnings expectations, with a reported earnings per share (EPS) of -$3.62.
Is it a good time to buy Moderna stock?
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Invest in Moderna sharesFinder Award
- Start investing from $50
- Pay no stamp duty on UK shares
- Commission-free trading. Other fees may apply.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Moderna under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Moderna P/E ratio, PEG ratio and EBITDA
Moderna's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Moderna shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Moderna's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $876 million (£0.0 million).
The EBITDA is a measure of a Moderna's overall financial performance and is widely used to measure a its profitability.
Sign up for weekly expert share tips
Join 50,000 subscribers who are notified about expert share tips. Plus a chance to win £500!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
More guides on Finder
-
How to buy Kyocera Corporation shares
Ever wondered how to buy shares in Kyocera? We explain how and compare a range of providers that can give you access to many brands, including Kyocera.
-
How to buy General Finance shares
Ever wondered how to buy shares in General Finance? We explain how and compare a range of providers that can give you access to many brands, including General Finance.
-
How to buy Baringsorate Investors shares
Ever wondered how to buy shares in Baringsorate Investors? We explain how and compare a range of providers that can give you access to many brands, including Baringsorate Investors.
-
How to buy 1st Source shares
Ever wondered how to buy shares in 1st Source? We explain how and compare a range of providers that can give you access to many brands, including 1st Source.
-
How to buy Eargo shares
Ever wondered how to buy shares in Eargo? We explain how and compare a range of providers that can give you access to many brands, including Eargo.
-
How to buy MediaAlpha shares
Ever wondered how to buy shares in MediaAlpha? We explain how and compare a range of providers that can give you access to many brands, including MediaAlpha.
-
How to buy Casper Sleep shares
Ever wondered how to buy shares in Casper Sleep? We explain how and compare a range of providers that can give you access to many brands, including Casper Sleep.
-
How to buy X Financial shares
Ever wondered how to buy shares in X Financial? We explain how and compare a range of providers that can give you access to many brands, including X Financial.
-
How to buy Capital City Bank Group shares
Ever wondered how to buy shares in Capital City Bank Group? We explain how and compare a range of providers that can give you access to many brands, including Capital City Bank Group.
-
How to buy Genpact shares
Ever wondered how to buy shares in Genpact? We explain how and compare a range of providers that can give you access to many brands, including Genpact.